Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPINE: Safety of continuing low-dose aspirin during spine surgery
jRCT1051240161Recruiting
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin in lumbar spinal stenosis (LSS), Herniated Lumbar Disk and cervical spondylomyelopathy (CSM) (2 arms). Primary endpoint: Total intraoperative and postoperative blood loss. Started Oct 2024; status: recruiting.
02
Drugs
aspirin
03
Conditions
lumbar spinal stenosis (LSS)Herniated Lumbar Diskcervical spondylomyelopathy (CSM)
Beyond the preview
Go deeper on jRCT1051240161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051240161.